News

Additional COVID-19 vaccine doses will soon be available in the U.S. to provide added protection against the coronavirus. But who is eligible for a third dose? And what can you expect if you need one?

The National Institute of Health and Care Excellence (NICE) has approved the use of a new drug combo – abemaciclib (Verzenios) and fulvestrant (Faslodex) – for some adults with an advanced form of breast cancer that’s spread to other parts of the body.

A team of researchers is expanding the precision and ability of CAR T-cell therapy in order to target solid tumors.

A team of researchers from Tel Aviv University has 3D-printed a first-of-its-kind glioblastoma tumor that could be used to improve treatment and accelerate the development of novel drugs.

Researchers have made a frightful finding by teasing out the circuits involved in producing a fear response in the brain and identified a type of brain wave that coordinated this reaction.

The role of nasal bacteria in the induction of virus-specific adaptive immunity is not clear. New research explores the role of nasal bacteria and provides clues to developing better intranasal vaccines for flu and COVID-19.

Researchers have discovered magnetic phenomena in antiferromagnets that could pave the way to developing faster and more efficient data storage.

According to a study, the delta variant of SARS-CoV-2 has caused hospitalizations and deaths, however, it is not particularly good at evading the antibodies generated by vaccination.

A survey of more than 17,000 pregnant and lactating individuals who received the COVID-19 vaccine showed that the individuals did not experience symptoms any more severe than their non-pregnant counterparts.

A study could elucidate how and why changes in the gut microbiota can alter the brain and behavior.